145 related articles for article (PubMed ID: 8356725)
1. Study of the effect of HLA class II antigens (serotyping and mixed lymphocyte reaction) on kidney graft outcome.
Ichikawa Y; Hashimoto M; Sata M; Fujimoto N; Kinoshita T; Kyo M; Kanda H; Ishibashi M; Fukunishi T; Amemiya H
Transplant Proc; 1993 Aug; 25(4):2710-2. PubMed ID: 8356725
[No Abstract] [Full Text] [Related]
2. Significant effect of HLA-DRB1 typing by linkage disequilibrium on kidney graft outcome.
Ichikawa Y; Hashimoto M; Nojima M; Sata M; Fujimoto N; Kyo M; Ishibashi M; Ohshima S; Amemiya H; Fukunishi T
Transplant Proc; 1993 Aug; 25(4):2707-9. PubMed ID: 8356724
[No Abstract] [Full Text] [Related]
3. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
[No Abstract] [Full Text] [Related]
4. Comparison of clinical response of DR-matched, MLC-compatible cadaver renal allografts and those from HLA-identical related donors.
Conti DJ; Andersen R; Soper WD; Wolf JS
Transplant Proc; 1987 Feb; 19(1 Pt 1):652-4. PubMed ID: 2978928
[No Abstract] [Full Text] [Related]
5. Genotyping analysis of HLA class II genes in donor-recipient kidney transplant pairs.
Papola F; Canossi A; Valeri M; Romano P; Contasta I; Torlone N; Liberatore G; Piazza A; Di Rocco M; Maccarone D
Transplant Proc; 1993 Dec; 25(6):3267-70. PubMed ID: 8266537
[No Abstract] [Full Text] [Related]
6. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
[No Abstract] [Full Text] [Related]
7. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
[TBL] [Abstract][Full Text] [Related]
8. Chimerism in survivors following allograft renal transplantation.
Lee JM; Lee CJ; Hu CY; Hsieh RP; Hu RH; Lee PH; Luh SP; Lee YC; Chu SH
Transplant Proc; 1996 Jun; 28(3):1285-7. PubMed ID: 8658662
[No Abstract] [Full Text] [Related]
9. Kidney transplantation at one center: 1-year results.
Haberal M; Bilgin N; Karakayali H; Arslan G; Büyükpamukçu N; Velidedeoğlu E; Turan M; Akkoç H; Moray G; Tezel E
Transplant Proc; 1996 Feb; 28(1):410-1. PubMed ID: 8644295
[No Abstract] [Full Text] [Related]
10. Influence of donor and recipient DRw6 status on outcome of cadaver kidney transplantation.
Vereerstraeten P; Andrien M; Dupont E; De Pauw L; Kinnaert P; Toussaint C
Transplant Proc; 1987 Feb; 19(1 Pt 1):708-10. PubMed ID: 3547836
[No Abstract] [Full Text] [Related]
11. Study of the effect of HLA-matched antigens shared between subsequent donors on the second kidney graft outcome.
Kabakov A; Suslov D; Bubnova L
Transplant Proc; 1995 Dec; 27(6):3460. PubMed ID: 8540050
[No Abstract] [Full Text] [Related]
12. Tissue typing in renal transplantation: the impact of cyclosporine.
Benvenisty AI; Cohen DJ; Hardy MA
Transplant Proc; 1986 Apr; 18(2 Suppl 1):19-28. PubMed ID: 2938321
[No Abstract] [Full Text] [Related]
13. Effect of flow cytometry, complement-dependent cytotoxicity, and auto cross match on cadaveric renal transplant outcome.
Christiaans M; Van den Berg-Loonen E; Ten Haaft A; Nieman F; Van Hooff J
Transplant Proc; 1995 Feb; 27(1):1028-30. PubMed ID: 7878788
[No Abstract] [Full Text] [Related]
14. Donor-specific hyporesponsiveness is observed in renal transplant patients who successfully maintain their renal function more than 6 years.
Kim YK; Ha J; Park MH; Kim SJ
Transplant Proc; 1996 Jun; 28(3):1235-6. PubMed ID: 8658639
[No Abstract] [Full Text] [Related]
15. Cadaver kidney graft outcome in relation to ischemia time and HLA match. Collaborative Transplant Study.
Opelz G
Transplant Proc; 1998 Dec; 30(8):4294-6. PubMed ID: 9865366
[No Abstract] [Full Text] [Related]
16. Strong impact of HLA-DR-matching on graft survival in 413 consecutive cadaver kidney transplants performed in Copenhagen over an eight-year period.
Jakobsen BK; Ryder LP; Ladefoged J; Løkkegaard H; Nielsen B; Olgaard K; Svejgaard A
Transplant Proc; 1995 Dec; 27(6):3452-3. PubMed ID: 8540048
[No Abstract] [Full Text] [Related]
17. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
Troppmann C; Almond PS; Payne WD; Dunn DL; Gores PF; Gruessner RW; Sutherland DE; Matas AJ; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
[No Abstract] [Full Text] [Related]
18. Association of HLA class I antigen matching and early graft outcome in living donor kidney transplantation.
Iqbal MM; Hossain RM; Rashid HU; Rahman MH; Datta M; Hassan MS
Transplant Proc; 2006 Sep; 38(7):2012-3. PubMed ID: 16979982
[TBL] [Abstract][Full Text] [Related]
19. Related donor kidney transplantation is the best form of treatment for uremia.
Groth CG; Fehrman I; Ringdén O; Lundgren G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893
[No Abstract] [Full Text] [Related]
20. [The dependence of the efficacy of cyclosporin A use in a kidney allograft on the degree of donor and recipient tissue compatibility based on HLA-DR antigens].
Abramov VIu; Kaluzhina NN; Otocheva LV; Zaretskaia IuM
Urol Nefrol (Mosk); 1993; (4):27-30. PubMed ID: 8310562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]